{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T18:04:05Z","timestamp":1778695445748,"version":"3.51.4"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,4,26]],"date-time":"2017-04-26T00:00:00Z","timestamp":1493164800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,4,26]],"date-time":"2017-04-26T00:00:00Z","timestamp":1493164800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R01GM094449"],"award-info":[{"award-number":["R01GM094449"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R21EY027065"],"award-info":[{"award-number":["R21EY027065"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21HD075372"],"award-info":[{"award-number":["R21HD075372"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["16PRE27250308"],"award-info":[{"award-number":["16PRE27250308"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["14PRE18310014"],"award-info":[{"award-number":["14PRE18310014"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Angiogenesis"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s10456-017-9557-6","type":"journal-article","created":{"date-parts":[[2017,4,26]],"date-time":"2017-04-26T08:52:43Z","timestamp":1493196763000},"page":"479-492","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Pathogenic role and therapeutic potential of pleiotrophin in mouse models of ocular vascular disease"],"prefix":"10.1007","volume":"20","author":[{"given":"Weiwen","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle E.","family":"LeBlanc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanli","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Brewer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha R.","family":"Spring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith A.","family":"Webster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9566-8764","authenticated-orcid":false,"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,26]]},"reference":[{"issue":"3","key":"9557_CR1","doi-asserted-by":"publisher","first-page":"556","DOI":"10.2337\/dc11-1909","volume":"35","author":"JW Yau","year":"2012","unstructured":"Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T et al (2012) Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 35(3):556\u2013564","journal-title":"Diabetes Care"},{"issue":"3","key":"9557_CR2","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1053\/j.semperi.2015.12.006","volume":"40","author":"KD Beharry","year":"2016","unstructured":"Beharry KD, Valencia GB, Lazzaro DR, Aranda JV (2016) Pharmacologic interventions for the prevention and treatment of retinopathy of prematurity. Semin Perinatol 40(3):189\u2013202","journal-title":"Semin Perinatol"},{"issue":"9902","key":"9557_CR3","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/S0140-6736(13)60178-6","volume":"382","author":"A Hellstrom","year":"2013","unstructured":"Hellstrom A, Smith LE, Dammann O (2013) Retinopathy of prematurity. Lancet 382(9902):1445\u20131457","journal-title":"Lancet"},{"issue":"2","key":"9557_CR4","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","volume":"2","author":"WL Wong","year":"2014","unstructured":"Wong WL, Su X, Li X, Cheung CM, Klein R, Cheng CY et al (2014) Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health 2(2):e106\u2013e116","journal-title":"Lancet Glob Health"},{"issue":"Pt 3","key":"9557_CR5","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/eye.2001.147","volume":"15","author":"M Votruba","year":"2001","unstructured":"Votruba M, Gregor Z (2001) Neovascular age-related macular degeneration: present and future treatment options. Eye (Lond) 15(Pt 3):424\u2013429","journal-title":"Eye (Lond)"},{"issue":"13","key":"9557_CR6","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1056\/NEJMoa1414264","volume":"372","author":"JA Wells","year":"2015","unstructured":"Diabetic Retinopathy Clinical Research Network, Wells JA, Glassman AR, Ayala AR, Jampol LM, Aiello LP et al (2015) Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med 372(13):1193\u20131203","journal-title":"N Engl J Med"},{"issue":"2","key":"9557_CR7","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.ajpath.2012.06.006","volume":"181","author":"LA Kim","year":"2012","unstructured":"Kim LA, D\u2019Amore PA (2012) A brief history of anti-VEGF for the treatment of ocular angiogenesis. Am J Pathol 181(2):376\u2013379","journal-title":"Am J Pathol"},{"key":"9557_CR8","first-page":"533","volume":"9","author":"VS Dedania","year":"2015","unstructured":"Dedania VS, Bakri SJ (2015) Current perspectives on ranibizumab. Clin Ophthalmol 9:533\u2013542","journal-title":"Clin Ophthalmol"},{"issue":"3","key":"9557_CR9","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1089\/nat.2015.0573","volume":"26","author":"DW Drolet","year":"2016","unstructured":"Drolet DW, Green LS, Gold L, Janjic N (2016) Fit for the eye: aptamers in ocular disorders. Nucleic Acid Ther 26(3):127\u2013146","journal-title":"Nucleic Acid Ther"},{"issue":"7","key":"9557_CR10","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1056\/NEJMoa1007374","volume":"364","author":"HA Mintz-Hittner","year":"2011","unstructured":"Mintz-Hittner HA, Kennedy KA, Chuang AZ, Group B-RC (2011) Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med 364(7):603\u2013615","journal-title":"N Engl J Med"},{"issue":"11","key":"9557_CR11","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/j.ophtha.2014.05.015","volume":"121","author":"D Lepore","year":"2014","unstructured":"Lepore D, Quinn GE, Molle F, Baldascino A, Orazi L, Sammartino M et al (2014) Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings. Ophthalmology 121(11):2212\u20132219","journal-title":"Ophthalmology"},{"issue":"2","key":"9557_CR12","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1006\/abbi.2001.2705","volume":"397","author":"TF Deuel","year":"2002","unstructured":"Deuel TF, Zhang N, Yeh HJ, Silos-Santiago I, Wang ZY (2002) Pleiotrophin: a cytokine with diverse functions and a novel signaling pathway. Arch Biochem Biophys 397(2):162\u2013171","journal-title":"Arch Biochem Biophys"},{"issue":"4","key":"9557_CR13","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1684\/ecn.2009.0172","volume":"20","author":"E Papadimitriou","year":"2009","unstructured":"Papadimitriou E, Mikelis C, Lampropoulou E, Koutsioumpa M, Theochari K, Tsirmoula S et al (2009) Roles of pleiotrophin in tumor growth and angiogenesis. Eur Cytokine Netw 20(4):180\u2013190","journal-title":"Eur Cytokine Netw"},{"issue":"17","key":"9557_CR14","doi-asserted-by":"crossref","first-page":"12999","DOI":"10.1016\/S0021-9258(18)99975-8","volume":"269","author":"E Raulo","year":"1994","unstructured":"Raulo E, Chernousov MA, Carey DJ, Nolo R, Rauvala H (1994) Isolation of a neuronal cell surface receptor of heparin binding growth-associated molecule (HB-GAM). Identification as N-syndecan (syndecan-3). J Biol Chem 269(17):12999\u201313004","journal-title":"J Biol Chem"},{"issue":"35","key":"9557_CR15","doi-asserted-by":"publisher","first-page":"32071","DOI":"10.1074\/jbc.M202747200","volume":"277","author":"I Bernard-Pierrot","year":"2002","unstructured":"Bernard-Pierrot I, Delbe J, Rouet V, Vigny M, Kerros ME, Caruelle D et al (2002) Dominant negative effectors of heparin affin regulatory peptide (HARP) angiogenic and transforming activities. J Biol Chem 277(35):32071\u201332077","journal-title":"J Biol Chem"},{"issue":"19","key":"9557_CR16","doi-asserted-by":"publisher","first-page":"4041","DOI":"10.1016\/j.yexcr.2007.07.032","volume":"313","author":"O Bermek","year":"2007","unstructured":"Bermek O, Diamantopoulou Z, Polykratis A, Dos Santos C, Hamma-Kourbali Y, Burlina F et al (2007) A basic peptide derived from the HARP C-terminus inhibits anchorage-independent growth of DU145 prostate cancer cells. Exp Cell Res 313(19):4041\u20134050","journal-title":"Exp Cell Res"},{"issue":"5","key":"9557_CR17","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1096\/fj.08-117564","volume":"23","author":"C Mikelis","year":"2009","unstructured":"Mikelis C, Sfaelou E, Koutsioumpa M, Kieffer N, Papadimitriou E (2009) Integrin alpha(v)beta(3) is a pleiotrophin receptor required for pleiotrophin-induced endothelial cell migration through receptor protein tyrosine phosphatase beta\/zeta. FASEB J. 23(5):1459\u20131469","journal-title":"FASEB J."},{"issue":"2","key":"9557_CR18","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0304-3835(03)00450-6","volume":"204","author":"K Kadomatsu","year":"2004","unstructured":"Kadomatsu K, Muramatsu T (2004) Midkine and pleiotrophin in neural development and cancer. Cancer Lett 204(2):127\u2013143","journal-title":"Cancer Lett"},{"issue":"6","key":"9557_CR19","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1073\/pnas.020487997","volume":"97","author":"K Meng","year":"2000","unstructured":"Meng K, Rodriguez-Pena A, Dimitrov T, Chen W, Yamin M, Noda M et al (2000) Pleiotrophin signals increased tyrosine phosphorylation of beta beta-catenin through inactivation of the intrinsic catalytic activity of the receptor-type protein tyrosine phosphatase beta\/zeta. Proc Natl Acad Sci USA 97(6):2603\u20132608","journal-title":"Proc Natl Acad Sci USA"},{"issue":"36","key":"9557_CR20","doi-asserted-by":"crossref","first-page":"25889","DOI":"10.1016\/S0021-9258(18)35692-8","volume":"267","author":"W Fang","year":"1992","unstructured":"Fang W, Hartmann N, Chow DT, Riegel AT, Wellstein A (1992) Pleiotrophin stimulates fibroblasts and endothelial and epithelial cells and is expressed in human cancer. J Biol Chem 267(36):25889\u201325897","journal-title":"J Biol Chem"},{"issue":"1","key":"9557_CR21","doi-asserted-by":"publisher","first-page":"e0115523","DOI":"10.1371\/journal.pone.0115523","volume":"10","author":"X Zhu","year":"2015","unstructured":"Zhu X, Bai Y, Yu W, Pan C, Jin E, Song D et al (2015) The effects of pleiotrophin in proliferative diabetic retinopathy. PLoS ONE 10(1):e0115523","journal-title":"PLoS ONE"},{"issue":"10","key":"9557_CR22","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1002\/j.1460-2075.1989.tb08443.x","volume":"8","author":"H Rauvala","year":"1989","unstructured":"Rauvala H (1989) An 18-kd heparin-binding protein of developing brain that is distinct from fibroblast growth factors. EMBO J 8(10):2933\u20132941","journal-title":"EMBO J"},{"issue":"3","key":"9557_CR23","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1097\/MOH.0b013e3282fdc69e","volume":"15","author":"P Perez-Pinera","year":"2008","unstructured":"Perez-Pinera P, Berenson JR, Deuel TF (2008) Pleiotrophin, a multifunctional angiogenic factor: mechanisms and pathways in normal and pathological angiogenesis. Curr Opin Hematol 15(3):210\u2013214","journal-title":"Curr Opin Hematol"},{"key":"9557_CR24","first-page":"374","volume":"22","author":"ME LeBlanc","year":"2016","unstructured":"LeBlanc ME, Wang W, Chen X, Ji Y, Shakya A, Shen C et al (2016) The regulatory role of hepatoma-derived growth factor as an angiogenic factor in the eye. Mol Vis 22:374\u2013386","journal-title":"Mol Vis"},{"issue":"2","key":"9557_CR25","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nprot.2007.30","volume":"2","author":"CC Liang","year":"2007","unstructured":"Liang CC, Park AY, Guan JL (2007) In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2(2):329\u2013333","journal-title":"Nat Protoc"},{"issue":"5","key":"9557_CR26","doi-asserted-by":"publisher","first-page":"e0127904","DOI":"10.1371\/journal.pone.0127904","volume":"10","author":"ME LeBlanc","year":"2015","unstructured":"LeBlanc ME, Wang W, Caberoy NB, Chen X, Guo F, Alvarado G et al (2015) Hepatoma-derived growth factor-related protein-3 is a novel angiogenic factor. PLoS ONE 10(5):e0127904","journal-title":"PLoS ONE"},{"issue":"2","key":"9557_CR27","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/jcp.21313","volume":"215","author":"C Heiss","year":"2008","unstructured":"Heiss C, Wong ML, Block VI, Lao D, Real WM, Yeghiazarians Y et al (2008) Pleiotrophin induces nitric oxide dependent migration of endothelial progenitor cells. J Cell Physiol 215(2):366\u2013373","journal-title":"J Cell Physiol"},{"issue":"6","key":"9557_CR28","first-page":"2337","volume":"118","author":"L Scheppke","year":"2008","unstructured":"Scheppke L, Aguilar E, Gariano RF, Jacobson R, Hood J, Doukas J et al (2008) Retinal vascular permeability suppression by topical application of a novel VEGFR2\/Src kinase inhibitor in mice and rabbits. J Clin Invest 118(6):2337\u20132346","journal-title":"J Clin Invest"},{"issue":"11","key":"9557_CR29","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1038\/nprot.2009.187","volume":"4","author":"KM Connor","year":"2009","unstructured":"Connor KM, Krah NM, Dennison RJ, Aderman CM, Chen J, Guerin KI et al (2009) Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis. Nat Protoc 4(11):1565\u20131573","journal-title":"Nat Protoc"},{"issue":"10","key":"9557_CR30","doi-asserted-by":"publisher","first-page":"6525","DOI":"10.1167\/iovs.14-15067","volume":"55","author":"SH Poor","year":"2014","unstructured":"Poor SH, Qiu Y, Fassbender ES, Shen S, Woolfenden A, Delpero A et al (2014) Reliability of the mouse model of choroidal neovascularization induced by laser photocoagulation. Invest Ophthalmol Vis Sci 55(10):6525\u20136534","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"9557_CR31","doi-asserted-by":"publisher","first-page":"e0120587","DOI":"10.1371\/journal.pone.0120587","volume":"10","author":"N Chan","year":"2015","unstructured":"Chan N, He S, Spee CK, Ishikawa K, Hinton DR (2015) Attenuation of choroidal neovascularization by histone deacetylase inhibitor. PLoS ONE 10(3):e0120587","journal-title":"PLoS ONE"},{"issue":"3","key":"9557_CR32","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.bbrc.2014.04.002","volume":"447","author":"JB Fan","year":"2014","unstructured":"Fan JB, Liu W, Yuan K, Zhu XH, Xu DW, Chen JJ et al (2014) EGFR trans-activation mediates pleiotrophin-induced activation of Akt and Erk in cultured osteoblasts. Biochem Biophys Res Commun 447(3):425\u2013430","journal-title":"Biochem Biophys Res Commun"},{"issue":"48","key":"9557_CR33","doi-asserted-by":"publisher","first-page":"34984","DOI":"10.1074\/jbc.M703513200","volume":"282","author":"J Li","year":"2007","unstructured":"Li J, Wei H, Chesley A, Moon C, Krawczyk M, Volkova M et al (2007) The pro-angiogenic cytokine pleiotrophin potentiates cardiomyocyte apoptosis through inhibition of endogenous AKT\/PKB activity. J Biol Chem 282(48):34984\u201334993","journal-title":"J Biol Chem"},{"issue":"9","key":"9557_CR34","first-page":"1814","volume":"57","author":"R Choudhuri","year":"1997","unstructured":"Choudhuri R, Zhang HT, Donnini S, Ziche M, Bicknell R (1997) An angiogenic role for the neurokines midkine and pleiotrophin in tumorigenesis. Cancer Res 57(9):1814\u20131819","journal-title":"Cancer Res"},{"issue":"1","key":"9557_CR35","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.cmet.2012.11.012","volume":"17","author":"C Rask-Madsen","year":"2013","unstructured":"Rask-Madsen C, King GL (2013) Vascular complications of diabetes: mechanisms of injury and protective factors. Cell Metab 17(1):20\u201333","journal-title":"Cell Metab"},{"issue":"6","key":"9557_CR36","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1167\/iovs.10-5176","volume":"51","author":"A Stahl","year":"2010","unstructured":"Stahl A, Connor KM, Sapieha P, Chen J, Dennison RJ, Krah NM et al (2010) The mouse retina as an angiogenesis model. Invest Ophthalmol Vis Sci 51(6):2813\u20132826","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9557_CR37","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2147\/EB.S94447","volume":"8","author":"CB Kim","year":"2016","unstructured":"Kim CB, D\u2019Amore PA, Connor KM (2016) Revisiting the mouse model of oxygen-induced retinopathy. Eye Brain 8:67\u201379","journal-title":"Eye Brain"},{"issue":"16","key":"9557_CR38","doi-asserted-by":"crossref","first-page":"11408","DOI":"10.1016\/S0021-9258(19)49925-0","volume":"267","author":"E Raulo","year":"1992","unstructured":"Raulo E, Julkunen I, Merenmies J, Pihlaskari R, Rauvala H (1992) Secretion and biological activities of heparin-binding growth-associated molecule. Neurite outgrowth-promoting and mitogenic actions of the recombinant and tissue-derived protein. J Biol Chem 267(16):11408\u201311416","journal-title":"J Biol Chem"},{"issue":"1","key":"9557_CR39","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/jcp.1041640107","volume":"164","author":"J Delbe","year":"1995","unstructured":"Delbe J, Vacherot F, Laaroubi K, Barritault D, Courty J (1995) Effect of heparin on bovine epithelial lens cell proliferation induced by heparin affin regulatory peptide. J Cell Physiol 164(1):47\u201354","journal-title":"J Cell Physiol"},{"issue":"1","key":"9557_CR40","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1006\/bbrc.2000.3126","volume":"274","author":"E Papadimitriou","year":"2000","unstructured":"Papadimitriou E, Heroult M, Courty J, Polykratis A, Stergiou C, Katsoris P (2000) Endothelial cell proliferation induced by HARP: implication of N or C terminal peptides. Biochem Biophys Res Commun 274(1):242\u2013248","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"9557_CR41","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1046\/j.1471-4159.2002.01179.x","volume":"83","author":"R Mentlein","year":"2002","unstructured":"Mentlein R, Held-Feindt J (2002) Pleiotrophin, an angiogenic and mitogenic growth factor, is expressed in human gliomas. J Neurochem 83(4):747\u2013753","journal-title":"J Neurochem"},{"issue":"4988","key":"9557_CR42","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1126\/science.2270483","volume":"250","author":"YS Li","year":"1990","unstructured":"Li YS, Milner PG, Chauhan AK, Watson MA, Hoffman RM, Kodner CM et al (1990) Cloning and expression of a developmentally regulated protein that induces mitogenic and neurite outgrowth activity. Science 250(4988):1690\u20131694","journal-title":"Science"},{"issue":"2","key":"9557_CR43","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/S0006-291X(05)80255-4","volume":"176","author":"J Tsutsui","year":"1991","unstructured":"Tsutsui J, Uehara K, Kadomatsu K, Matsubara S, Muramatsu T (1991) A new family of heparin-binding factors: strong conservation of midkine (MK) sequences between the human and the mouse. Biochem Biophys Res Commun 176(2):792\u2013797","journal-title":"Biochem Biophys Res Commun"},{"issue":"35","key":"9557_CR44","doi-asserted-by":"publisher","first-page":"12162","DOI":"10.1523\/JNEUROSCI.2127-15.2015","volume":"35","author":"K Kuboyama","year":"2015","unstructured":"Kuboyama K, Fujikawa A, Suzuki R, Noda M (2015) Inactivation of protein tyrosine phosphatase receptor type Z by pleiotrophin promotes remyelination through activation of differentiation of oligodendrocyte precursor cells. J Neurosci 35(35):12162\u201312171","journal-title":"J Neurosci"},{"issue":"1","key":"9557_CR45","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0006-291X(05)81267-7","volume":"180","author":"J Courty","year":"1991","unstructured":"Courty J, Dauchel MC, Caruelle D, Perderiset M, Barritault D (1991) Mitogenic properties of a new endothelial cell growth factor related to pleiotrophin. Biochem Biophys Res Commun 180(1):145\u2013151","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"9557_CR46","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s00384-011-1344-z","volume":"27","author":"Y Kong","year":"2012","unstructured":"Kong Y, Bai PS, Nan KJ, Sun H, Chen NZ, Qi XG (2012) Pleiotrophin is a potential colorectal cancer prognostic factor that promotes VEGF expression and induces angiogenesis in colorectal cancer. Int J Colorectal Dis 27(3):287\u2013298","journal-title":"Int J Colorectal Dis"},{"issue":"2","key":"9557_CR47","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1073\/pnas.90.2.679","volume":"90","author":"AK Chauhan","year":"1993","unstructured":"Chauhan AK, Li YS, Deuel TF (1993) Pleiotrophin transforms NIH 3T3 cells and induces tumors in nude mice. Proc Natl Acad Sci USA 90(2):679\u2013682","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"9557_CR48","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.cyto.2013.02.002","volume":"62","author":"S Besse","year":"2013","unstructured":"Besse S, Comte R, Frechault S, Courty J, de Joel L, Delbe J (2013) Pleiotrophin promotes capillary-like sprouting from senescent aortic rings. Cytokine 62(1):44\u201347","journal-title":"Cytokine"},{"issue":"2","key":"9557_CR49","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.bbrc.2006.03.006","volume":"343","author":"N Zhang","year":"2006","unstructured":"Zhang N, Zhong R, Perez-Pinera P, Herradon G, Ezquerra L, Wang ZY et al (2006) Identification of the angiogenesis signaling domain in pleiotrophin defines a mechanism of the angiogenic switch. Biochem Biophys Res Commun 343(2):653\u2013658","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"9557_CR50","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1042\/BJ20110301","volume":"437","author":"S Koch","year":"2011","unstructured":"Koch S, Tugues S, Li X, Gualandi L, Claesson-Welsh L (2011) Signal transduction by vascular endothelial growth factor receptors. Biochem J 437(2):169\u2013183","journal-title":"Biochem J"},{"issue":"12","key":"9557_CR51","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1016\/j.biocel.2008.04.009","volume":"40","author":"JW Ramos","year":"2008","unstructured":"Ramos JW (2008) The regulation of extracellular signal-regulated kinase (ERK) in mammalian cells. Int J Biochem Cell Biol 40(12):2707\u20132719","journal-title":"Int J Biochem Cell Biol"},{"issue":"4","key":"9557_CR52","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.3892\/or.2016.4994","volume":"36","author":"L Hu","year":"2016","unstructured":"Hu L, Wang J, Wang Y, Xu H (2016) An integrin alphavbeta3 antagonistic modified peptide inhibits tumor growth through inhibition of the ERK and AKT signaling pathways. Oncol Rep 36(4):1953\u20131962","journal-title":"Oncol Rep"},{"key":"9557_CR53","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2174\/2213988501307010009","volume":"7","author":"H Eishingdrelo","year":"2013","unstructured":"Eishingdrelo H, Kongsamut S (2013) Minireview: targeting GPCR activated ERK pathways for drug discovery. Curr Chem Genom Transl Med 7:9\u201315","journal-title":"Curr Chem Genom Transl Med"},{"issue":"4935","key":"9557_CR54","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1126\/science.2479987","volume":"246","author":"PJ Keck","year":"1989","unstructured":"Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J et al (1989) Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246(4935):1309\u20131312","journal-title":"Science"},{"issue":"4935","key":"9557_CR55","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1126\/science.2479986","volume":"246","author":"DW Leung","year":"1989","unstructured":"Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N (1989) Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246(4935):1306\u20131309","journal-title":"Science"},{"issue":"3","key":"9557_CR56","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1167\/iovs.13-13397","volume":"55","author":"CC Tokunaga","year":"2014","unstructured":"Tokunaga CC, Mitton KP, Dailey W, Massoll C, Roumayah K, Guzman E et al (2014) Effects of anti-VEGF treatment on the recovery of the developing retina following oxygen-induced retinopathy. Invest Ophthalmol Vis Sci 55(3):1884\u20131892","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"406","key":"9557_CR57","doi-asserted-by":"publisher","first-page":"ra125","DOI":"10.1126\/scisignal.aaa1690","volume":"8","author":"L Zhang","year":"2015","unstructured":"Zhang L, Kundu S, Feenstra T, Li X, Jin C, Laaniste L et al (2015) Pleiotrophin promotes vascular abnormalization in gliomas and correlates with poor survival in patients with astrocytomas. Sci Signal 8(406):ra125","journal-title":"Sci Signal"},{"issue":"9","key":"9557_CR58","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1038\/sj.onc.1206879","volume":"23","author":"M Heroult","year":"2004","unstructured":"Heroult M, Bernard-Pierrot I, Delbe J, Hamma-Kourbali Y, Katsoris P, Barritault D et al (2004) Heparin affin regulatory peptide binds to vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis. Oncogene 23(9):1745\u20131753","journal-title":"Oncogene"},{"key":"9557_CR59","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12943-015-0287-3","volume":"14","author":"M Koutsioumpa","year":"2015","unstructured":"Koutsioumpa M, Poimenidi E, Pantazaka E, Theodoropoulou C, Skoura A, Megalooikonomou V et al (2015) Receptor protein tyrosine phosphatase beta\/zeta is a functional binding partner for vascular endothelial growth factor. Mol Cancer 14:19","journal-title":"Mol Cancer"},{"issue":"2","key":"9557_CR60","first-page":"252","volume":"1866","author":"E Papadimitriou","year":"2016","unstructured":"Papadimitriou E, Pantazaka E, Castana P, Tsalios T, Polyzos A, Beis D (2016) Pleiotrophin and its receptor protein tyrosine phosphatase beta\/zeta as regulators of angiogenesis and cancer. Biochim Biophys Acta 1866(2):252\u2013265","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"9557_CR61","first-page":"629","volume":"20","author":"G Kokolakis","year":"2006","unstructured":"Kokolakis G, Mikelis C, Papadimitriou E, Courty J, Karetsou E, Katsoris P (2006) Effect of heparin affin regulatory peptide on the expression of vascular endothelial growth factor receptors in endothelial cells. Vivo. 20(5):629\u2013635","journal-title":"Vivo."},{"issue":"46","key":"9557_CR62","doi-asserted-by":"publisher","first-page":"30336","DOI":"10.1074\/jbc.273.46.30336","volume":"273","author":"HP Gerber","year":"1998","unstructured":"Gerber HP, McMurtrey A, Kowalski J, Yan M, Keyt BA, Dixit V et al (1998) Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3\u2032-kinase\/Akt signal transduction pathway. Requirement for Flk-1\/KDR activation. J Biol Chem 273(46):30336\u201330343","journal-title":"J Biol Chem"},{"issue":"2","key":"9557_CR63","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1167\/iovs.09-4144","volume":"51","author":"SH Byeon","year":"2010","unstructured":"Byeon SH, Lee SC, Choi SH, Lee HK, Lee JH, Chu YK et al (2010) Vascular endothelial growth factor as an autocrine survival factor for retinal pigment epithelial cells under oxidative stress via the VEGF-R2\/PI3K\/Akt. Invest Ophthalmol Vis Sci 51(2):1190\u20131197","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"35","key":"9557_CR64","doi-asserted-by":"crossref","first-page":"11036","DOI":"10.1523\/JNEUROSCI.23-35-11036.2003","volume":"23","author":"JM Rosenstein","year":"2003","unstructured":"Rosenstein JM, Mani N, Khaibullina A, Krum JM (2003) Neurotrophic effects of vascular endothelial growth factor on organotypic cortical explants and primary cortical neurons. J Neurosci 23(35):11036\u201311044","journal-title":"J Neurosci"},{"issue":"4","key":"9557_CR65","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1084\/jem.20161802","volume":"214","author":"ME LeBlanc","year":"2017","unstructured":"LeBlanc ME, Wang W, Chen X, Caberoy NB, Guo F, Shen C et al (2017) Secretogranin III as a disease-associated ligand for antiangiogenic therapy of diabetic retinopathy. J Exp Med 214(4):1029\u20131047","journal-title":"J Exp Med"},{"issue":"2","key":"9557_CR66","doi-asserted-by":"publisher","first-page":"970","DOI":"10.3390\/cancers2020970","volume":"2","author":"KD Lynn","year":"2010","unstructured":"Lynn KD, Roland CL, Brekken RA (2010) VEGF and pleiotrophin modulate the immune profile of breast cancer. Cancers (Basel) 2(2):970\u2013988","journal-title":"Cancers (Basel)"}],"container-title":["Angiogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10456-017-9557-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10456-017-9557-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10456-017-9557-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T22:58:15Z","timestamp":1658962695000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10456-017-9557-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,26]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["9557"],"URL":"https:\/\/doi.org\/10.1007\/s10456-017-9557-6","relation":{},"ISSN":["0969-6970","1573-7209"],"issn-type":[{"value":"0969-6970","type":"print"},{"value":"1573-7209","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,26]]},"assertion":[{"value":"27 November 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing or financial interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}